How to Deal With Eczema in Winter

Winter can be a challenging time of year for individuals who suffer with skin disorders such as atopic dermatitis (also known as eczema) and psoriasis. It is this time of year when the air is dry that skin conditions tend to flare up or worsen.

Eczema is a skin disorder associated with rashes of dry, and extremely itchy skin resulting in red, swollen, and crusty skin from scratching. It most commonly affects the hands, face, feet, elbows, and behind the knees. Most often, eczema among kids shows up on the cheeks, or in the folds of the arms and legs https://uvb-lamps.com/blog/how-to-detect-whether-or-not-your-child-has-an-eczema/. While the exact cause of eczema is not known, it is believed to occur from a combination of genetic and enivornmental factors. On the other hand, psoriasis is believed to be an autoimmune disorder in which skin cells overproduce and cause dry, scaly patches of skin.

Fortunately, there are many treatments for eczema and psoriasis available, and we will cover one of the most effective ones – phototherapy eczema treatment.

Light therapy, which emits artificial sunlight using special Philips bulbs, has shown to be an effective approach for treating eczema and psoriasis in the majority of individuals who have tried it. Narrowband UVB 311nm phototherapy has been proven to be more effective than broadband UVB and PUVA light therapy treatments.
Today people have more opportunities to treat skin disorders using a UVB lamp for psoriasis https://uvb-lamps.com/product/uvb-lamp-psoriasis/ or eczema, and it is very convenient in handling skin problems all year long, especially during dry winter months. The benefits of this therapy include targeted treatment (exposing only affected skin to the UVB radiation), and convenience and cost effectiveness (can be administered any time of the day in a preferred setting, and does not require multiple trips to a doctor’s office or clinic each week).

Posted: March 10, 2013 by Michael Banson 88
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...